Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Os... (at are derived from relationships may be...)

Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis

Date:9/13/2009

at are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no gu
'/>"/>

SOURCE Amgen Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine technology :

1. Research: Popular Diabetes Medications Associated with Increase in Bone Fractures
2. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
3. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
4. New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug
5. Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms
6. Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
7. CareHeres Electronic Medication System Proves 100 Percent Effective in Response to Recall
8. American Lung Association Study to be Published in the New England Journal of Medicine Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought
9. Parkinsons Disease Medication Triggers Destructive Behaviors
10. Aching Back? Cholesterol Medication Might Help
11. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults

Post Your Comments:

(Date:12/16/2009)... -- Accuray Incorporated (Nasdaq: ARAY ), a global ... its president and chief executive officer, Euan S. Thomson, ... J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ... ,, A live webcast of each presentation will ... the Company,s Web site at http://www.accuray.com . ...

(Date:12/16/2009)... DATATRAK International, Inc. (OTCQX: DATA), ... global eClinical solutions for the clinical trials ... version 9.0 eClinical Software. This release ... and service delivery and introduces two new ... the DATATRAK Learning Center(TM) and the DATATRAK ...

(Date:12/16/2009)... -- HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an online ... million in 12% per annum short term debt financing. ... initial drawdown of $500,000, with accrued interest and principal ... with accrued interest and principal repayable in one year ... cashflow positive for any calendar month prior to December ...

[0] Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference [0] DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM)[0] HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing

... Program to Advance to the Clinic Within a Year; Studies ... Generate Milestone Payment to ... Inc. (Nasdaq: MITI ) and Nycomed today announced the ... MT203.,Micromet received $775,000 (500,000 euros) from Nycomed for the achievement,of ...

... Companies confirm the start of TRILOGY ACS clinical trial ... medically managed ACS patients, TOKYO and INDIANAPOLIS, June ... and Company (NYSE: LLY ),said that the U.S. ... for the prasugrel new drug application (NDA) based on,supplemental ...

Other Medicine Technology:Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 2 Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 3 Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 4 FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 2 FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 3 FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 4

Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel

(Date:12/17/2009)... Motionsoft, Inc. announced today that it ... (PCI) Data Security Standards (DSS) certification, making it ... in the health and wellness space that has ... is the result of a collaborative effort formed ... International, MasterCard Worldwide, American Express, Discover Financial Services ...

(Date:12/17/2009)... PHILADELPHIA, Dec. 17 The recently opened ... already out in the community in full force this ... Run on December 13th, benefiting the Arthritis Foundation, a ... of arthritis. The event boasted 1,500 attendees, spotlighting LSI,s ... Run is a renowned, national fundraiser and a festive ...

(Date:12/17/2009)... and glutathione S-transferase T1 (GSTT1) null genotypes have been ... regarding the association between GSTM1 and GSTT1 null genotypes ... However, the majority of previous reports are limited by ... GSTM1/GSTT1 null genotype with the risk of GC and ... numbers of samples. , A research article to ...

(Date:12/17/2009)... DIEGO (December 17, 2009) Researchers from the ... aim at several of the world,s most dangerous infectious ... a five-year, $18.8 million federally-funded set of projects seeking ... , The Institute received four project awards ... and Infectious Diseases (NIAID), part of the National Institutes ...

(Date:12/17/2009)... one day provide therapeutic options for muscle and bone ... the umbilical cord, just as the blood that goes ... disorders, said University of Pittsburgh School of Medicine researchers ... Journal of Biomedicine and Biotechnology . , Umbilical ... are remarkably stable and might not trigger strong immune ...

Breaking Medicine News(10 mins):Health News:Motionsoft Completes PCI Compliance Certification 2 Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2 Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 2 Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 3 Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 4 Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 5 Health News:Umbilical cord could be new source of plentiful stem cells, say Pitt researchers 2

[0] Motionsoft Completes PCI Compliance Certification [0] Laser Spine Institute (LSI) Supports Jingle Bell Run [0] Does Glutathione-S-transferase associate with gastrointestinal cancer in Korean population?[0] NIH awards La Jolla Institute $18.8 million for major infectious disease study [0] Umbilical cord could be new source of plentiful stem cells, say Pitt researchers

... to the memory and scientific accomplishments of Dr. Judah ... and shed light on the link between blood supply ... (Volume 6, Number 3-4) of Lymphatic Research and ... the research impact of one of the pre-eminent physician-scientists ...

... a child born with cleft lip and palate often have ... a normal life. For some, this year,s resolution will ... philanthropy, members of the American Society of Plastic Surgeons (ASPS) ... give than to receive," by traveling overseas on behalf of ...

... Calif., Jan. 7 The surgical lights are on, ... West Coast,s most,advanced pediatric surgery center, at Lucile Packard ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090107/AQW023 ) , ... in December, provide the,latest in imaging and communication technologies, ...

... ZMH ; SWX: ZMH) announced today it will be ... on January 13, 2009,at 12:00 p.m. Eastern Time. , ... via Zimmer,s Investor,Relations website at http://investor.zimmer.com . The webcast ... About the Company , Founded in ...

... admission PHILADELPHIA, Jan. 7 /PRNewswire/ -- ... year,s Healthy Kids Fest on Sunday, January 11, 2009, at ... to 5 p.m. Just in time for those New Year,s ... and free activities for the whole family.The Blue Cross RiverRink ...

... L.P. today announced that it has settled a lawsuit brought ... in October 2005 pertaining to Medicaid reimbursements paid by the ... a full release of claims, Dey has agreed to pay ... 2007 acquisition agreement between Mylan Inc. (Dey,s parent company) and ...

Other Medicine News:Health News:Festschrift Issue honoring Judah Folkman, M.D., in Lymphatic Research and Biology 2 Health News:New year brings new hope to children born with cleft lip, palate 2 Health News:Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center 2 Health News:Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center 3 Health News:Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center 4 Health News:Families Encouraged to Enjoy Healthy Kids Fest at the Blue Cross RiverRink January 11 2 Health News:Dey L.P. Settles State of Mississippi Pricing Litigation 2

Festschrift Issue honoring Judah Folkman, M.D., in Lymphatic Research and Biology New year brings new hope to children born with cleft lip, palate Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center Zimmer Holdings to Present at 27th Annual JP Morgan Healthcare Conference Families Encouraged to Enjoy Healthy Kids Fest at the Blue Cross RiverRink January 11 Dey L.P. Settles State of Mississippi Pricing Litigation

... MJS anatomic knee system ... durability, minimize polyethylene wear ... to minimize contact stress ... to achieve a well ...

The Balanced Knee™ system provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....

... a cruciate sparing version which provides ... both resurfacing and inset patellas. Precision ... and fit with tibial articular surface ... cutting guide peg locations provide easy ...

... a femoral option and tibial insert which provides ... 60 degrees of flexion to induce a smooth ... degrees of flexion. Femoral component comes in a ... The constrained tibial insert in conjunction with the ...

Medicine Products:

MJS™ Anatomic Knee System Balanced Knee™ System Optetrak Cruciate Retaining Foundation® Posterior Stabilized Knee

Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Os...(at are derived from relationships may be...),Health